News

Revlon Reports Third Quarter 2022 Results

Nov 08, 2022

NEW YORK--(BUSINESS WIRE)--Nov. 8, 2022-- Revlon, Inc. (“Revlon” and together with its subsidiaries, the “Company”) today announced its results for the quarter ended September 30, 2022, in its Form 10-Q filed with the Securities and Exchange Commission (the “SEC”). On June 15, 2022, the Company commenced a voluntary Chapter 11 financial restructuring supported by $575 million of new money debtor-in-possession financing. As of November 8, 2022, the Company remains in Chapter 11. Due to the pending Chapter 11 cases, the Company will not host an earnings call this quarter.

 

 

Three Months Ended September 30,
(Unaudited)

 

 

2022

 

2021

 

As Reported

 

Adjusted (*)

(USD millions, except per share data)

 

As Reported

 

Adjusted (*)

 

As Reported

 

Adjusted (*)

 

% Change

 

% Change

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Sales

 

$

468.4

 

 

$

468.4

 

 

$

521.1

 

 

$

521.1

 

 

(10.1

) %

 

(10.1

) %

Gross Profit

 

$

260.9

 

 

$

260.9

 

 

$

299.9

 

 

$

300.0

 

 

(13.0

) %

 

(13.0

) %

Gross Margin

 

 

55.7

%

 

 

55.7

%

 

 

57.6

%

 

 

57.6

%

 

-190bps

 

-190bps

Operating Income

 

$

12.9

 

 

$

16.8

 

 

$

34.1

 

 

$

47.3

 

 

(62.2

) %

 

(64.5

) %

Net Loss

 

 

(152.8

)

 

 

(149.2

)

 

 

(53.1

)

 

 

(40.2

)

 

(187.8

) %

 

(271.1

) %

Adjusted EBITDA

 

 

 

 

50.3

 

 

 

 

 

82.4

 

 

 

 

(39.0

) %

Diluted Loss per Common Share

 

$

(2.77

)

 

$

(2.71

)

 

$

(0.98

)

 

$

(0.74

)

 

(182.7

) %

 

(266.2

) %

(*) In calculating Adjusted results, adjustments were made for the Non-Operating Items and the EBITDA Exclusions in the case of Adjusted EBITDA, in each case as described in footnote (a) in this press release.

Third Quarter Financial Results1

  • As Reported net sales were $468.4 million in the third quarter of 2022, compared to $521.1 million during the prior-year period, a decrease of $52.7 million, or 10.1%. The As Reported net sales decrease of $52.7 million includes unfavorable FX impacts totaling $25.8 million, resulting in a $26.9 million decrease on an XFX basis.
  • As Reported operating income was $12.9 million in the third quarter of 2022, compared to an operating income of $34.1 million during the prior-year period, a decrease of $21.2 million. The lower operating income was driven primarily by lower As Reported net sales, a gross margin decline of -190bps, offset by $7.6 million in lower selling, general and administrative expenses (SG&A), and $9.7 million in lower restructuring charges. Adjusted operating income in the third quarter of 2022 decreased by $30.5 million to $16.8 million from $47.3 million over the prior-year period.
  • Adjusted EBITDA(a) in the third quarter of 2022 was $50.3 million, versus $82.4 million in the prior-year period. The lower Adjusted EBITDA was driven primarily by lower As Reported net sales and lower As Reported operating income.
  • As Reported net loss was $152.8 million in the third quarter of 2022, versus a $53.1 million net loss in the prior-year period. The higher net loss was primarily driven by $85 million of charges related to the Company's Chapter 11 filing, lower operating income, and higher foreign currency losses of $9.5 million, offset by $2.6 million in lower tax provisions and $6.9 million of lower interest expense over the prior-year period.
  • Net cash used in operating activities for the first nine months of 2022 was $251.0 million, compared to a $86.7 million use of cash in the prior-year period. The increase in cash used in operating activities was primarily driven by a higher As Reported net loss, unfavorable working capital changes, and cash expenditures related to the Chapter 11 Cases. Free cash flow(a) in the first nine months of 2022 was a $259.1 million use of cash, compared to a $93.0 million use of cash in the prior-year period.
  • As of September 30, 2022, the Company had approximately $273.4 million of available liquidity, consisting of $246.4 million of unrestricted cash and cash equivalents, $29.6 million of undrawn availability under the Company's Super-Priority Senior Secured Debtor-In-Possession Asset-Based Revolving Credit Agreement (the "DIP ABL Revolver"), less float of approximately $2.6 million.

1 The results discussed include the following measures: U.S. GAAP (“As Reported”); and non-GAAP (“Adjusted”), which excludes certain Non-Operating Items and EBITDA Exclusions (as defined in Footnote (a)) from As Reported results. See footnote (a) for further discussion of the Company’s Adjusted measures. Reconciliations of As Reported results to Adjusted results are provided as an attachment to this release. In addition, where indicated, the Company analyzes and presents its results excluding the impact of foreign currency translation (“XFX”). Unless otherwise noted, the discussion is presented on an As Reported basis.

 

Financial Restructuring and Chapter 11 Process

  • As previously announced, Revlon, Inc. and certain of its subsidiaries in the United States, Canada, and United Kingdom (the “Debtors”) filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code (the "Chapter 11 Cases") on June 15, 2022, in the U.S. Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”). The Company commenced the Chapter 11 Cases to implement a comprehensive financial restructuring of Revlon’s legacy capital structure and improve its long-term outlook.
  • Pursuant to motions filed with the Bankruptcy Court, the Bankruptcy Court authorized the Debtors to conduct their business activities in the ordinary course.
  • In connection with the Chapter 11 Cases, the Company has received $575 million of new money debtor-in-possession financing under a superpriority, senior secured and priming term loan credit facility from certain of its existing lenders (the “DIP Term Loan,” and along with the DIP ABL Revolver, the “DIP Financing”). The Company also entered into the superpriority, senior secured and priming DIP ABL Revolver, which provided one tranche of $270 million in revolving commitments (subject to a borrowing base limit) and refinanced approximately $109 million of asset-backed revolving prepetition debt, and a second tranche that refinances an additional $130 million in prepetition debt. The proceeds of the DIP Financing were used to refinance certain of the Company’s debt obligations and are being used for general corporate purposes. The DIP Financing is expected to provide sufficient liquidity to support the Company’s ordinary course operations.
  • Information related to the Chapter 11 Cases is included in the Company’s Form 10-Q for the quarterly period ended September 30, 2022 filed with the SEC and on the Company’s investor relations website. Additional information, including court filings and other documents related to the court-supervised process, is available on the Company’s restructuring website at https://cases.ra.kroll.com/Revlon, by emailing revloninfo@ra.kroll.com or by calling (855) 631-5341 (toll free) or (646) 795-6968 (international).
 

About Revlon, Inc.

Revlon, Inc. is a leading global beauty company with a portfolio of iconic brands that transform the lives of women and men around the world. Our Company manufactures and markets color cosmetics, hair color and care, skincare, beauty care and fragrances through a diverse portfolio of 15+ brands sold in more than 150 countries.

 

Footnotes to Press Release

(a) Non-GAAP Financial Measures: EBITDA; Adjusted EBITDA; Adjusted net sales; Adjusted operating loss/income; Adjusted net income/loss; Adjusted gross profit; Adjusted gross profit margin; Adjusted diluted loss per common share and free cash flow (together, the “Non-GAAP Measures”) are non-GAAP financial measures. See the reconciliations of such Non-GAAP Measures to their most directly comparable GAAP measures in the accompanying financial tables, to the extent not otherwise directly reconciled in the Company’s financial results.

The Company defines EBITDA as income from continuing operations before interest, taxes, depreciation, amortization, gains/losses on foreign currency fluctuations, gains/losses on the early extinguishment of debt and miscellaneous expenses (the foregoing being the “EBITDA Exclusions”). The Company presents Adjusted EBITDA to exclude the EBITDA Exclusions, as well as the impact of non-cash stock-based compensation expense and certain other non-operating items that are not directly attributable to the Company's underlying operating performance (the “Non-Operating Items”). The following table identifies the Non-Operating Items excluded in the presentation of Adjusted EBITDA for all periods:

(USD millions)

Q3 2022

Q3 2021

Net Loss Adjustments to EBITDA

 

(Unaudited)

Non-Operating Items:

 

Non-cash stock-based compensation expense

$

7.2

$

3.9

 

Restructuring and related charges

 

3.5

 

10.8

 

Acquisition, integration and divestiture costs

 

0.2

 

0.6

 

Gain on divested assets

 

 

0.1

 

COVID-19 charges

 

 

(0.1

)

Capital structure and related charges

 

0.2

 

1.8

 

Adjusted net loss and adjusted diluted loss per common share exclude the after-tax impact of the Non-Operating Items from As Reported net loss.

The Company excludes the EBITDA Exclusions and Non-Operating Items, as applicable, in calculating the Non-GAAP Measures because the Company's management believes that some of these items may not occur in certain periods, the amounts recognized can vary significantly from period to period and/or these items do not facilitate an understanding of the Company's underlying operating performance.

Free cash flow is defined as net cash provided by/used in operating activities, less capital expenditures for property, plant and equipment. Free cash flow excludes proceeds on sale of discontinued operations. Free cash flow does not represent the residual cash flow available for discretionary expenditures, as it excludes certain expenditures such as mandatory debt service requirements, which for the Company are significant.

The Company's management uses the Non-GAAP Measures as operating performance measures, and in the case of free cash flow, as a liquidity measure (in conjunction with GAAP financial measures), as an integral part of its reporting and planning processes and to, among other things: (i) monitor and evaluate the performance of the Company's business operations, financial performance and overall liquidity; (ii) facilitate management's internal comparisons of the Company's historical operating performance of its business operations; (iii) facilitate management's external comparisons of the results of its overall business to the historical operating performance of other companies that may have different capital structures and debt levels; (iv) review and assess the operating performance of the Company's management team and, together with other operational objectives, as a measure in evaluating employee compensation, including bonuses and other incentive compensation; (v) analyze and evaluate financial and strategic planning decisions regarding future operating investments; and (vi) plan for and prepare future annual operating budgets and determine appropriate levels of operating investments.

 

Management believes that the Non-GAAP Measures are useful to investors to provide them with disclosures of the Company's operating results on the same basis as that used by management. Management believes that the Non-GAAP Measures provide useful information to investors about the performance of the Company's overall business because such measures eliminate the effects of certain charges that are not directly attributable to the Company's underlying operating performance. Additionally, management believes that providing the Non-GAAP Measures enhances the comparability for investors in assessing the Company’s financial reporting. Management believes that free cash flow is useful for investors because it provides them with an important perspective on the cash available for debt service and other strategic measures, after making necessary capital investments in property and equipment to support the Company's ongoing business operations, and provides them with the same measures that management uses as the basis for making resource allocation decisions.

Accordingly, the Company believes that the presentation of the Non-GAAP Measures, when used in conjunction with GAAP financial measures, are useful financial analytical measures that are used by management, as described above, and therefore can assist investors in assessing the Company's financial condition, operating performance and underlying strength. The Non-GAAP Measures should not be considered in isolation or as a substitute for their respective most directly comparable As Reported financial measures prepared in accordance with GAAP, such as net income/loss, operating income/loss, diluted earnings/loss per share or net cash provided by (used in) operating activities. Other companies may define such non-GAAP measures differently. Also, while EBITDA and Adjusted EBITDA, as used in this release, are defined differently than Adjusted EBITDA for the Company's credit agreements and indentures, certain financial covenants in its borrowing arrangements are tied to similar financial measures. These non-GAAP financial measures should be read in conjunction with the Company's financial statements and related footnotes filed with the SEC.

(b) Segment profit is defined as income from continuing operations for each of the Company's Revlon, Elizabeth Arden, Portfolio and Fragrances segments, excluding the EBITDA Exclusions. Segment profit also excludes the impact of certain items that are not directly attributable to the segments' underlying operating performance, including the impact of the Non-Operating Items noted above in footnote (a). The Company does not have any material inter-segment sales.

FORWARD-LOOKING STATEMENTS

Statements made in this press release, which are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking and are provided pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by, among other things, the use of forward-looking language such as "estimates," "objectives," "visions," "projects," "forecasts," "focus," "drive towards," "future," "plans," "targets," "strategies," "opportunities," "assumptions," "drivers," "believes," "intends," "outlooks," "initiatives," "expects," "scheduled to," "anticipates," "seeks," "may," "will" or "should" or the negative of those terms, or other variations of those terms or comparable language, or by discussions of strategies, targets, long-range plans, models or intentions. Forward-looking statements speak only as of the date they are made, and except for the Company's ongoing obligations under the U.S. federal securities laws, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are based on preliminary or potentially inaccurate estimates and assumptions and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from forward-looking statements, including, but not limited to various risks associated with the Chapter 11 Cases, including, but not limited to, the Debtors’ ability to obtain Bankruptcy Court approval with respect to motions in the bankruptcy petitions, the effects of the bankruptcy petitions on the Company and on the interests of various stakeholders, Bankruptcy Court rulings during the Chapter 11 Cases and the outcome of the Chapter 11 Cases in general, the length of time the Debtors will remain in Chapter 11, risks associated with any third-party motions during the Chapter 11 Cases, the potential adverse effects of the Chapter 11 Cases on the Company’s liquidity or results of operations and increased legal and other professional costs necessary to execute the Company’s reorganization, the conditions to which the Company’s debtor-in-possession financing is subject and the risk that these conditions may not be satisfied for various reasons, including for reasons outside of the Company’s control, whether the Company will emerge, in whole or in part, from insolvency proceedings as a going concern, employee attrition and the Company’s ability to retain senior management and other key personnel due to the distractions and uncertainties imposed in part by the Chapter 11 Cases and the trading price and volatility of the Company’s common stock. Actual results may also differ materially from the Company's forward-looking statements as a result of the risks and other items described in Revlon’s filings with the SEC, including, without limitation, in Revlon’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K and amendments thereto, if any, filed with the SEC (which may be viewed on the SEC’s website at http://www.sec.gov or on Revlon, Inc.’s website at http://www.revloninc.com). Factors other than those referred to above could also cause Revlon’s results to differ materially from expected results. Additionally, the business and financial materials and any other statement or disclosure on, or made available through, Revlon’s website or other websites referenced herein shall not be incorporated by reference into this press release.

The Company cautions that trading in the Company’s securities during the pendency of the Chapter 11 Cases is highly speculative and poses substantial risks. Trading prices for the Company’s securities may bear little or no relationship to the actual recovery, if any, by holders of the Company’s securities in the Chapter 11 Cases. Holders of shares of the Company’s common stock could experience a complete loss on their investment, depending on the outcome of the Chapter 11 Cases.

 
 

REVLON, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(dollars in millions, except share and per share amounts)

 

 

 

 

 

 

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

(Unaudited)

 

(Unaudited)

 

 

 

 

 

 

 

 

Net sales

$

468.4

 

 

$

521.1

 

 

$

1,390.6

 

 

$

1,463.5

 

Cost of sales

 

207.5

 

 

 

221.2

 

 

 

595.8

 

 

 

608.7

 

Gross profit

 

260.9

 

 

 

299.9

 

 

 

794.8

 

 

 

854.8

 

Selling, general and administrative expenses

 

248.5

 

 

 

256.1

 

 

 

758.4

 

 

 

796.0

 

Acquisition, integration and divestiture costs

 

0.2

 

 

 

0.6

 

 

 

0.7

 

 

 

1.8

 

Restructuring charges and other, net

 

(0.7

)

 

 

9.0

 

 

 

4.3

 

 

 

22.8

 

Impairment charges

 

 

 

 

 

 

 

24.3

 

 

 

 

Gain on divested assets

 

 

 

 

0.1

 

 

 

 

 

 

(1.7

)

Operating income (loss)

 

12.9

 

 

 

34.1

 

 

 

7.1

 

 

 

35.9

 

 

 

 

 

 

 

 

 

Other expenses:

 

 

 

 

 

 

 

Interest expense, net

 

56.2

 

 

 

63.1

 

 

 

175.8

 

 

 

183.9

 

Amortization of debt issuance costs

 

 

 

 

8.7

 

 

 

20.9

 

 

 

30.7

 

Foreign currency losses, net

 

19.4

 

 

 

9.9

 

 

 

41.4

 

 

 

11.5

 

Miscellaneous, net

 

2.3

 

 

 

0.1

 

 

 

9.0

 

 

 

2.8

 

Reorganization items, net

 

85.0

 

 

 

 

 

 

243.3

 

 

 

 

Other expenses

 

162.9

 

 

 

81.8

 

 

 

490.4

 

 

 

228.9

 

 

 

 

 

 

 

 

 

Loss from operations before income taxes

 

(150.0

)

 

 

(47.7

)

 

 

(483.3

)

 

 

(193.0

)

(Benefit from) provision for income taxes

 

2.8

 

 

 

5.4

 

 

 

12.1

 

 

 

23.8

 

Net loss

$

(152.8

)

 

$

(53.1

)

 

$

(495.4

)

 

$

(216.8

)

 

 

 

 

 

 

 

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

(6.2

)

 

 

(0.6

)

 

 

(8.2

)

 

 

(6.0

)

Amortization of pension related costs, net of tax

 

2.9

 

 

 

3.5

 

 

 

8.6

 

 

 

10.5

 

Other comprehensive income (loss), net

 

(3.3

)

 

 

2.9

 

 

 

0.4

 

 

 

4.5

 

Total comprehensive loss

$

(156.1

)

 

$

(50.2

)

 

$

(495.0

)

 

$

(212.3

)

 

 

 

 

 

 

 

 

Basic and Diluted loss per common share:

$

(2.77

)

 

$

(0.98

)

 

$

(9.04

)

 

$

(4.02

)

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

Basic

 

55,111,423

 

 

 

54,025,861

 

 

 

54,818,140

 

 

 

53,899,732

 

Diluted

 

55,111,423

 

 

 

54,025,861

 

 

 

54,818,140

 

 

 

53,899,732

 

                               
 
 

REVLON, INC. AND SUBSIDIARIES

CONSOLIDATED CONDENSED BALANCE SHEETS

(dollars in millions)

 

 

 

 

 

September 30,

 

December 31,

 

 

2022

 

 

 

2021

 

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

246.4

 

 

$

102.4

 

Trade receivables, net

 

319.0

 

 

 

383.8

 

Inventories, net

 

456.0

 

 

 

417.4

 

Prepaid expenses and other current assets

 

217.2

 

 

 

136.0

 

Total current assets

 

1,238.6

 

 

 

1,039.6

 

Property, plant and equipment, net

 

249.9

 

 

 

297.3

 

Deferred income taxes

 

41.2

 

 

 

42.8

 

Goodwill

 

561.2

 

 

 

562.8

 

Intangible assets, net

 

335.4

 

 

 

392.2

 

Other assets

 

94.3

 

 

 

97.8

 

Total assets

$

2,520.6

 

 

$

2,432.5

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIENCY

 

 

 

Current liabilities:

 

 

 

Short-term borrowings

$

0.6

 

 

$

0.7

 

Current portion of long-term debt

 

746.9

 

 

 

137.2

 

Accounts payable

 

105.0

 

 

 

217.7

 

Accrued expenses and other current liabilities

 

392.1

 

 

 

432.0

 

Total current liabilities

 

1,244.6

 

 

 

787.6

 

Long-term debt

 

0.1

 

 

 

3,305.5

 

Long-term pension and other post-retirement plan liabilities

 

85.4

 

 

 

147.3

 

Other long-term liabilities

 

72.5

 

 

 

206.2

 

Liabilities subject to compromise

 

3,615.1

 

 

 

 

Total stockholders' deficiency

 

(2,497.1

)

 

 

(2,014.1

)

Total liabilities and stockholders' deficiency

$

2,520.6

 

 

$

2,432.5

 

               
 
 

REVLON, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in millions)

 

Nine Months Ended

 

September 30,

 

 

2022

 

 

 

2021

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

Net loss

$

(495.4

)

 

$

(216.8

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Depreciation and amortization

 

80.7

 

 

 

96.8

 

Foreign currency losses from re-measurement

 

41.4

 

 

 

11.5

 

Amortization of debt discount

 

0.3

 

 

 

0.7

 

Stock-based compensation amortization

 

15.3

 

 

 

10.4

 

Impairment charges

 

24.3

 

 

 

 

(Benefit from) provision for deferred income taxes

 

(0.2

)

 

 

3.9

 

Amortization of debt issuance costs

 

20.9

 

 

 

30.7

 

Gain on divested assets

 

 

 

 

(1.7

)

Non-cash reorganization items, net

 

131.5

 

 

 

 

Pension and other post-retirement cost

 

3.7

 

 

 

3.6

 

Paid-in-kind interest expense on the 2020 BrandCo Facilities

 

19.0

 

 

 

14.1

 

Change in assets and liabilities:

 

 

 

Decrease (increase) in trade receivables

 

45.4

 

 

 

(44.4

)

(Increase) in inventories

 

(55.4

)

 

 

(8.1

)

Decrease (increase) in prepaid expenses and other current assets

 

(85.9

)

 

 

0.2

 

Increase (decrease) in accounts payable

 

(3.6

)

 

 

56.1

 

Increase (decrease) in accrued expenses and other current liabilities

 

40.2

 

 

 

(25.2

)

Decrease in deferred revenue

 

(2.0

)

 

 

(2.0

)

Pension and other post-retirement plan contributions

 

(4.4

)

 

 

(20.5

)

Purchases of permanent displays

 

(15.6

)

 

 

(15.0

)

Other, net

 

(11.2

)

 

 

19.0

 

Net cash used in operating activities

 

(251.0

)

 

 

(86.7

)

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

Capital expenditures

 

(8.1

)

 

 

(6.3

)

Proceeds from the sale of certain assets

 

 

 

 

2.1

 

Net cash used in investing activities

 

(8.1

)

 

 

(4.2

)

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

Net decrease in short-term borrowings and overdraft

 

(0.6

)

 

 

(12.5

)

Borrowings on term loans

 

 

 

 

305.0

 

Repayments on term loans

 

(88.6

)

 

 

(186.7

)

Net (repayments) borrowings under the revolving credit facilities

 

(0.6

)

 

 

(2.7

)

Borrowings on DIP Term Loan Facility

 

575.0

 

 

 

 

Repayments on Tranche A DIP ABL Facility

 

(67.2

)

 

 

 

Payment of financing costs

 

(18.8

)

 

 

(17.9

)

Tax withholdings related to net share settlements of restricted stock and RSUs

 

(3.3

)

 

 

(2.4

)

Other financing activities

 

(0.2

)

 

 

(0.3

)

Net cash provided by financing activities

 

395.7

 

 

 

82.5

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

(7.3

)

 

 

(2.4

)

Net increase in cash, cash equivalents and restricted cash

 

129.3

 

 

 

(10.8

)

Cash, cash equivalents and restricted cash at beginning of period

 

120.9

 

 

 

102.5

 

Cash, cash equivalents and restricted cash at end of period

$

250.2

 

 

$

91.7

 

 

 

 

 

Supplemental schedule of cash flow information:

 

 

 

Cash paid during the period for:

 

 

 

Interest

$

159.1

 

 

$

186.4

 

Income taxes, net of refunds

 

7.1

 

 

 

7.3

 

Reorganization items, net

 

69.5

 

 

 

 

Supplemental schedule of non-cash investing and financing activities:

 

 

 

Paid-in-kind interest capitalized to the 2020 BrandCo Facilities

 

19.0

 

 

 

14.1

 

               
 
 

REVLON, INC. AND SUBSIDIARIES

EBITDA AND ADJUSTED EBITDA RECONCILIATION

(dollars in millions)

 

 

 

 

 

Three Months Ended
September 30,

 

 

2022

 

 

 

2021

 

 

(Unaudited)

Reconciliation to net (loss) income:

 

 

 

Net loss

$

(152.8

)

 

$

(53.1

)

Interest expense, net

 

56.2

 

 

 

63.1

 

Amortization of debt issuance costs

 

 

 

 

8.7

 

Foreign currency losses, net

 

19.4

 

 

 

9.9

 

Provision for income taxes

 

2.8

 

 

 

5.4

 

Depreciation and amortization

 

26.3

 

 

 

31.2

 

Miscellaneous, net

 

2.3

 

 

 

0.1

 

Reorganization items, net

 

85.0

 

 

 

 

 

 

 

 

EBITDA

$

39.2

 

 

$

65.3

 

 

 

 

 

Non-operating items:

 

 

 

Non-cash stock-based compensation expense

 

7.2

 

 

 

3.9

 

Restructuring and related charges

 

3.5

 

 

 

10.8

 

Acquisition, integration and divestiture costs

 

0.2

 

 

 

0.6

 

Loss on divested assets

 

 

 

 

0.1

 

Financial control remediation and sustainability actions and related charges

 

 

 

 

 

Impairment charges

 

 

 

 

 

COVID-19 charges

 

 

 

 

(0.1

)

Capital structure and related charges

 

0.2

 

 

 

1.8

 

 

 

 

 

Adjusted EBITDA

$

50.3

 

 

$

82.4

 

 

 

 

 

 

Nine Months Ended September 30,

 

 

2022

 

 

 

2021

 

 

(Unaudited)

Reconciliation to net (loss) income:

 

 

 

Net loss

$

(495.4

)

 

$

(216.8

)

Interest expense, net

 

175.8

 

 

 

183.9

 

Amortization of debt issuance costs

 

20.9

 

 

 

30.7

 

Foreign currency losses, net

 

41.4

 

 

 

11.5

 

Provision for income taxes

 

12.1

 

 

 

23.8

 

Depreciation and amortization

 

80.7

 

 

 

96.8

 

Miscellaneous, net

 

9.0

 

 

 

2.8

 

Reorganization items, net

 

243.3

 

 

 

 

EBITDA

$

87.8

 

 

$

132.7

 

 

 

 

 

Non-operating items:

 

 

 

Non-cash stock-based compensation expense

 

15.3

 

 

 

10.4

 

Restructuring and related charges

 

28.5

 

 

 

28.0

 

Acquisition, integration and divestiture costs

 

0.7

 

 

 

1.8

 

Gain on divested assets

 

 

 

 

(1.7

)

Financial control remediation and sustainability actions and related charges

 

 

 

 

0.4

 

Impairment charges

 

24.3

 

 

 

 

COVID-19 charges

 

 

 

 

6.1

 

Capital structure and related charges

 

3.9

 

 

 

6.8

 

 

 

 

 

Adjusted EBITDA

$

160.5

 

 

$

184.5

 

               
 
 

REVLON, INC. AND SUBSIDIARIES

SEGMENT PROFIT, ADJUSTED EBITDA AND ADJUSTED OPERATING LOSS RECONCILIATION

(dollars in millions)

 

 

 

 

 

 

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

(Unaudited)

 

(Unaudited)

 

 

 

 

 

 

 

 

Segment Profit:

 

 

 

 

 

 

 

Revlon

$

13.8

 

 

$

16.1

 

 

$

62.1

 

 

$

45.3

 

Elizabeth Arden

 

16.0

 

 

 

21.3

 

 

 

39.9

 

 

 

42.1

 

Portfolio

 

3.5

 

 

 

22.1

 

 

 

25.7

 

 

 

46.3

 

Fragrances

 

17.0

 

 

 

22.9

 

 

 

32.8

 

 

 

50.8

 

Total Segment Profit/Adjusted EBITDA

$

50.3

 

 

$

82.4

 

 

$

160.5

 

 

$

184.5

 

 

 

 

 

 

 

 

 

Reconciliation to (loss) income from continuing operations before income taxes:

 

 

 

 

 

 

 

Loss from operations before income taxes

$

(150.0

)

 

$

(47.7

)

 

$

(483.3

)

 

$

(193.0

)

 

 

 

 

 

 

 

 

Interest expense, net

 

56.2

 

 

 

63.1

 

 

 

175.8

 

 

 

183.9

 

Amortization of debt issuance costs

 

 

 

 

8.7

 

 

 

20.9

 

 

 

30.7

 

Foreign currency losses, net

 

19.4

 

 

 

9.9

 

 

 

41.4

 

 

 

11.5

 

Miscellaneous, net

 

2.3

 

 

 

0.1

 

 

 

9.0

 

 

 

2.8

 

Reorganization items, net

 

85.0

 

 

 

 

 

 

243.3

 

 

 

 

Operating income (loss)

 

12.9

 

 

 

34.1

 

 

 

7.1

 

 

 

35.9

 

 

 

 

 

 

 

 

 

Non-operating items:

 

 

 

 

 

 

 

Restructuring and related charges

 

3.5

 

 

 

10.8

 

 

 

28.5

 

 

 

28.0

 

Acquisition, integration and divestiture costs

 

0.2

 

 

 

0.6

 

 

 

0.7

 

 

 

1.8

 

Gain (Loss) on divested assets

 

 

 

 

0.1

 

 

 

 

 

 

(1.7

)

Financial control remediation and sustainability actions and related charges

 

 

 

 

 

 

 

 

 

 

0.4

 

Impairment charges

 

 

 

 

 

 

 

24.3

 

 

 

 

COVID-19 charges

 

 

 

 

(0.1

)

 

 

 

 

 

6.1

 

Capital structure and related charges

 

0.2

 

 

 

1.8

 

 

 

3.9

 

 

 

6.8

 

Adjusted Operating income

 

16.8

 

 

 

47.3

 

 

 

64.5

 

 

 

77.3

 

 

 

 

 

 

 

 

 

Non-cash stock-based compensation expense

 

7.2

 

 

 

3.9

 

 

 

15.3

 

 

 

10.4

 

Depreciation and amortization

 

26.3

 

 

 

31.2

 

 

 

80.7

 

 

 

96.8

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

50.3

 

 

$

82.4

 

 

$

160.5

 

 

$

184.5

 

                               
 

REVLON, INC. AND SUBSIDIARIES

 

ADJUSTED NET SALES RECONCILIATION

 

(dollars in millions)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

2022

 

2021

 

2022

 

2021

 

 

(Unaudited)

 

(Unaudited)

 

Segment Net Sales

 

 

 

 

 

 

 

 

Revlon

$

176.6

 

$

173.0

 

$

544.9

 

$

521.8

 

Elizabeth Arden

 

120.7

 

 

122.8

 

 

347.7

 

 

359.7

 

Portfolio

 

83.0

 

 

112.7

 

 

268.4

 

 

307.4

 

Fragrances

 

88.1

 

 

112.6

 

 

229.6

 

 

274.6

 

Total Segment Net Sales

$

468.4

 

$

521.1

 

$

1,390.6

 

$

1,463.5

 

                         
 
 

ADJUSTED GROSS PROFIT RECONCILIATION

(dollars in millions)

 

 

 

 

 

 

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

2022

 

2021

 

2022

 

2021

 

(Unaudited)

 

(Unaudited)

Gross Profit

$

260.9

 

$

299.9

 

$

794.8

 

$

854.8

Non-operating items:

 

 

 

 

 

 

 

COVID-19 charges

 

 

 

0.1

 

 

 

 

5.4

Adjusted Gross Profit

$

260.9

 

$

300.0

 

$

794.8

 

$

860.2

                       
 
 

REVLON, INC. AND SUBSIDIARIES

ADJUSTED NET INCOME (LOSS) AND ADJUSTED DILUTED INCOME (LOSS) PER SHARE RECONCILIATION

(dollars in millions, except share and per share amounts)

 

 

 

 

 

Three Months Ended
September 30,

 

 

2022

 

 

 

2021

 

 

(Unaudited)

Reconciliation to net loss and diluted loss per share:

 

 

 

Net (loss) income

$

(152.8

)

 

$

(53.1

)

 

 

 

 

Non-operating items (after-tax):

 

 

 

Restructuring and related charges

 

3.2

 

 

 

10.5

 

Acquisition, integration and divestiture costs

 

0.2

 

 

 

0.6

 

Loss (gain) on divested assets

 

 

 

 

0.1

 

Financial control remediation and sustainability actions and related charges

 

 

 

 

 

Impairment charges

 

 

 

 

 

COVID-19 charges

 

 

 

 

(0.1

)

Capital structure and related charges

 

0.2

 

 

 

1.8

 

Adjusted net loss

$

(149.2

)

 

$

(40.2

)

 

 

 

 

Net (loss) income:

 

 

 

Diluted (loss) income per common share

 

(2.77

)

 

 

(0.98

)

Adjustment to diluted (loss) income per common share

 

0.06

 

 

 

0.24

 

Adjusted diluted (loss) income per common share

$

(2.71

)

 

$

(0.74

)

 

 

 

 

U.S. GAAP weighted average number of common shares outstanding:

 

 

 

Diluted

 

55,111,423

 

 

 

54,025,861

 

 

 

 

 

 

Nine Months Ended
September 30,

 

 

2022

 

 

 

2021

 

 

(Unaudited)

Reconciliation to net loss and diluted loss per share:

 

 

 

Net loss

$

(495.4

)

 

$

(216.8

)

 

 

 

 

Non-operating items (after-tax):

 

 

 

Restructuring and related charges

 

28.1

 

 

 

26.7

 

Acquisition, integration and divestiture costs

 

0.7

 

 

 

1.8

 

Gain on divested assets

 

 

 

 

(1.7

)

Financial control remediation and sustainability actions and related charges

 

 

 

 

0.4

 

Impairment charges

 

24.3

 

 

 

 

COVID-19 charges

 

 

 

 

4.8

 

Capital structure and related charges

 

3.9

 

 

 

6.8

 

Adjusted net loss

$

(438.4

)

 

$

(178.0

)

 

 

 

 

Net loss:

 

 

 

Diluted loss per common share

 

(9.04

)

 

 

(4.02

)

Adjustment to diluted loss per common share

 

1.04

 

 

 

0.72

 

Adjusted diluted loss per common share

$

(8.00

)

 

$

(3.30

)

 

 

 

 

U.S. GAAP weighted average number of common shares outstanding:

 

 

 

Diluted

 

54,818,140

 

 

 

53,899,732

 

 

 

 

 

 
 

REVLON, INC. AND SUBSIDIARIES

FREE CASH FLOW RECONCILIATION

(dollars in millions)

 

 

 

 

 

Nine Months Ended
September 30,

 

 

2022

 

 

 

2021

 

 

(Unaudited)

Reconciliation to net cash provided by (used in) operating activities:

 

 

 

Net cash used in operating activities

$

(251.0

)

 

$

(86.7

)

Less capital expenditures

 

(8.1

)

 

 

(6.3

)

 

 

 

 

Free cash flow

$

(259.1

)

 

$

(93.0

)

 

Investor Website: investors.revlon.com
Investor Relations: investor.relations@revlon.com

Source: Revlon